COMPREHENSIVE TREATMENT OF PATIENTS WITH CHRONIC BRAIN ISCHEMIA. PURPOSEFUL CORRECTION OF COGNITIVE IMPAIRMENT AND RECOVERY OF MOTOR FUNCTIONS AFTER A STROKE
ARTICLE PDF (Українська)

Keywords

chronic brain ischemia, complex treatment, programmatic stimulation of muscles

How to Cite

Cherniy, T., Fokina, D., & Cherniy, V. (2020). COMPREHENSIVE TREATMENT OF PATIENTS WITH CHRONIC BRAIN ISCHEMIA. PURPOSEFUL CORRECTION OF COGNITIVE IMPAIRMENT AND RECOVERY OF MOTOR FUNCTIONS AFTER A STROKE. Clinical and Preventive Medicine, (4), 33-43. https://doi.org/10.31612/2616-4868.4(14).2020.02

Abstract

Background. Vascular cerebral pathology, caused by a slowly progressing diffuse insufficiency of blood supply to brain tissue, leads to a progressive impairment of brain function, is a predictor of stroke, shaping the development of immune failure of brain tissue. Perspective direction of protection of the brain from chronic ischemia – direct influence on the systems of neurotransmitters and neuromodulators of the brain, normalization of the ratio of the processes of excitatory and inhibitory neurotransmission, individual approach to the restoration of impaired functions, activation of additional reserves of the brain, based on different treatments.

Aim: to develop a method of complex treatment of patients with chronic brain ischemia (CВI), stroke, which includes targeted correction of cognitive impairment and restoration of motor functions.

Material and methods. In the period from 2016 to 2019, a total of 118 people aged 51 to 78 years with chronic cerebral ischemia without concomitant hypertension, with a history of hypertension, with CBI and a stroke with a history without movement disorders, and with disorders of arbitrary disorders were comprehensively examined, with the formation of persistent neurological deficit. Among the examined patients were 40 men and 78 women. The diagnosis was confirmed by the data of general clinical, neurological, laboratory, instrumental examination, neuropsychological testing (MMSE, DASS-21). In addition to the protocol, patients with CBI received a complex of drugs aimed at the correction of neurotransmitter metabolism: ipidacrine hydrochloride monohydrate, choline alphoscerate, citicolin for 14 days. In patients with impaired arbitrary movements additionally used the hardware-software complex «Trenar-01» in the program «Donor».

Results. Supplementation of the protocol of treatment of patients with CBI in all study groups with a complex of drugs aimed at eliminating cholinergic insufficiency led to the correction of cognitive disorders in chronic brain ischemia. The use of the hardware-software complex «Trenar-01» in the course of treatment repeatedly increases the strength and function of stimulated muscles, which allows normalizing static and motor disorders faster.

Conclusion. The complex of drugs aimed at eliminating cholinergic insufficiency, the use of the apparatus for electrical stimulation with biocontrol «Trenar-01» leads to the correction of cognitive impairment and the restoration of arbitrary movements in patients with CBI who have suffered a stroke with motor disorders.

https://doi.org/10.31612/2616-4868.4(14).2020.02
ARTICLE PDF (Українська)

References

ChukanovaYe.I., KhodzhamzharovB.E., ChukanovaA.S.(2012). Khronicheskayaishemiyamozga (etiologiya, patogenez, lecheniye).Profilaktikainsul'taisosudistoydementsii[Chronic cerebral ischemia (etiology, pathogenesis, treatment)].RMZH,10, 517.

GusevYe.I., Konovalov A.N., Skvortsova V.I. i dr. (2010)Khronicheskayanedostatochnost' mozgovogokrovoobrashcheniya [Chronic cerebrovascular insufficiency]Nevrologiya. Natsional'noyerukovodstvo. M.: GEOTAR. Media., 336.

Zhivolupov C.A., Samartsev I.N., Syroyezhkin F.A. (2013) Sovremennayakontseptsiyaneyroplastichnosti (teoreticheskiyeaspektyiprakticheskayaznachimost') [The modern concept of neuroplasticity (theoretical aspects and practical significance)].Zhurnalnevrologiiipsikhiatrii, 113, 10,102-108.

KharchenkoYe.P., Klimenko M.N. (2004) Plastichnost' mozga [Plasticity of the brain].Khimiyaizhizn', 6, 26-33.

Odinak M.M., Zhivolupov S.A., Panomarev V.V., Rashidov N.A., Samartsev I.N. (2014) Vosstanovleniyesoznaniyakakproyavleniyeneyroplastichnosti [Recovery of consciousness as a manifestation of neuroplasticity]. Voprosyneyrokhirurgii, 1, 33-41.

Belenichev I.F., Cherniy V.I. i dr. (2015) Neyroprotektsiyaineyroplastichnost' [Neuroprotection and neuroplasticity]. K.: Logos, 512.

Cherniy V.I., Andronova I.A., Cherniy T.V. (2018)Ostrayaikhronicheskayaishemiyamozga. Postishemicheskiyekognitivnyyenarusheniya.Kontseptsiyaneyroplastichnosti [Acute and chronic cerebral ischemia.Postischemic cognitive impairment.The concept of neuroplasticity].Kiyev «Olfa», 52.

Damulin I.V., Zhivolupov S.A., Zaytsev O.S., Maksimova M.YU., Markin S.P., Samartsev I.N., Sanadze A.G., Strokov I.A. (2016) Neyromidin v klinicheskoypraktike [Neuromidin in clinical practice]. M.: OOO «Meditsinskoyeinformatsionnoyeagentstvo», 64.

Gomazkov O.A. (2014) Neyrogenezkakadaptivnayafunktsiyamozga [Neurogenesis as an adaptive brain function].InstitutbiomeditsinskoykhimiiimeniV.N.Orekhovicha.Moskva, 85.

Cherniy T.V., Andronova M.A., Cherniy V.I., Andronova I.A. (2018)Tselenapravlennayamedikamentoznayakorrektsiyakognitivnykhnarusheniy u bol'nykh s khronicheskoyishemiyeymozga [Targeted medical correction of cognitive impairment in patients with chronic cerebral ischemia]. Zhurnalnevrologíí̈ ím..B.M. Man'kovs'kogo, 6, 1, 5-16.

Biotekhnicheskiyesistemyupravleniyadvigatel'nymifunktsiyamicheloveka ISSN 2519-2205 (Online), ISSN 0454-9910 (Print) (2017) [Biotechnological systems for controlling human motor functions ISSN 2519-2205 (Online), ISSN 0454-9910 (Print)]. Kib.ivych. tekhn, 1, 187, 55.

Vovk M.I. (2017) Biotekhnicheskiyesistemyupravleniyadvigatel'nymifunktsiyamicheloveka [Biotechnical systems for controlling human motor functions].Kib.ivych. tekhn.,1, 187, 49–65.

ESH/ESC guidelinesfor the management of arterialhypertension: the TaskForcefor the Management of ArterialHypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (2013) EurHeart J., 34, 2159–2219.

Klinichnyyprotokolnadannyamedychnoyidopomohykhvorymnadystsyrkulyatornuentsefalopatiyu [Clinical protocol of medical care for patients with dyscirculatory encephalopathy]. Kod MKKH-10.Dodatok do nakazu MOZ №487 vid 17-08-2007.

Xu J, et al. (2019) Safety and efficacy of EdaravoneDexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial.Stroke and Vascular Neurology, 4, e000221.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.